Cognizant Technology Solutions Corp vs Twist Bioscience Corp — how do they compare? Cognizant Technology Solutions Corp trades at $58.28 (market cap $26.40B), while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: Cognizant Technology Solutions Corp is far larger — about 3.4× Twist Bioscience Corp's market cap, and Cognizant Technology Solutions Corp pays a 2.25% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| CTSH | TWST | |
|---|---|---|
Market Cap | $26.40B | $7.72B |
Sector | Technology | Health |
52-Week High | $86.70 | $124.88 |
52-Week Low | $38.73 | $24.16 |
Enterprise Value | $27.44B | $7.65B |
Dividend Yield | 2.25% | — |
Trailing returns across standard periods
Cognizant is a global IT services provider, offering consulting and outsourcing services to some of the world's largest enterprises spanning the financial services, media and communications, healthcare, natural resources, and consumer products industries. Cognizant employs nearly 300,000 people globally, roughly 70% of whom are in India, although the company's headquarters are in Teaneck, New Jersey.
Read more on CTSH →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →